TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Relief dimension score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Communication dimension score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Death or disabling stroke
Endpoint domain: Mortality/survival
Primary endpoint: OKNf (Optokinetic Nystagmus frequency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OKNg (Optokinetic Nystagmus gain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac death-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: All-cause death-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Amplitude of the ST segment 20 msec after the end of QRS (ST20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Two-legged knee extensor endurance exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle CS activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of sinus bradycardia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of premature atrial contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional outcome (HHS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SF-12 physical component score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to loss of therapeutic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of coronary atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bone Mineral Density (BMD) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean T score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shorter period of obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower rate of immediate complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change from baseline in HIV‐1 RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable microbiological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of emotional dysregulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of Giardia infection
Endpoint domain: Adverse events/effects
Primary endpoint: regression of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in affected limb size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hernia recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HIV risk perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HIV knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: LPS plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: LBP plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Urinary HVA excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competitive employment rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Approximate entropy correlation with remifentanil concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signal-to-noise ratio of electroencephalographic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of average maximal electroencephalographic effect to interindividual baseline variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pleasantness ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: N-terminal pro-brain natriuretic peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to complete re-epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBeAg absence rates at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HBeAg seroconversion rates at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Normalization of ALT levels at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: abscess rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Areas under the response curve to OGTT for glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Areas under the response curve to OGTT for C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Si values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: drinks per drinking day (DPDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in DBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: DPPH radical scavenging activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BASDAI50 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BASFI improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: highest clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapeutic failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: median time to ambulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical condition improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodic secondary memory improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diurnal IOP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet accumulation in vascular grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: TUG test on postoperative day 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MDI (Mental Developmental Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of foundational EBP concepts
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fitzpatrick Wrinkle Scale score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced exercise capacity (V(O)(2), mL*kg(‐1)*min(‐1))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPEPS values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in GH scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination of necessity for gingivectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to enter medical history data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean inaccuracies in medical history data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-pass intubation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean value of keratinized tissue (KT) height after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: No pain or only mild pain reported
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Body sway velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postoperative edemas
Endpoint domain: Adverse events/effects
Primary endpoint: General Health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of cancer
Endpoint domain: Mortality/survival
Primary endpoint: Risk of abdominal operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: postoperative catheter time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: post-operative embolisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Severity of retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and efficacy of iopromide for peripheral arteriography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation severity (CAS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Glycemic control (HbA1c, FPG, PPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of PLSP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: verbal pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of subjects experiencing injection pain
Endpoint domain: Adverse events/effects
Primary endpoint: SS-QOL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: thinking ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: LH suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Testosterone suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Duration of testosterone suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: acquisition of clinical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of severity of alopecia tool score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Constant‐Murley scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Site‐specific quality of life improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: recurrent HD onset < 34 weeks gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of new vertebral compression fractures (VCFs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of further height loss in treated vertebrae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confusion scale improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: chest tightness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Major grade 3/4 adverse events during NAC
Endpoint domain: Adverse events/effects
Primary endpoint: Delivery before 34 weeks
Endpoint domain: Mortality/survival
Primary endpoint: incidence of low cardiac output syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: biochemically confirmed abstinence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative alveolar osteitis
Endpoint domain: Adverse events/effects
Primary endpoint: Plasmatic levels of IL-1beta, IL-6, and IL-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Oxygen partial pressure to inspired oxygen fraction ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative mechanical ventilation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reporting of work-related symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reporting of home-related symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: penicillin treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the serum insulin curve after oral glucose administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Basal serum 17 alpha-hydroxyprogesterone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total iodine content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute error in force replication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional treatment results (BSVL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of pneumococcal vaccination in preventing pneumococcal bacteremia
Endpoint domain: Mortality/survival
Primary endpoint: Seroconversion rate at Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average Break-Up Time (AVBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluorescein Break-Up Time (FBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal TSH values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Biphasic thyroiditis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Caller satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance with advice given
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Repeat calls for advice
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Ease of airway maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median SpO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time following the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of the second stage of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: a/A pO2 ratio at 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: duration of nCPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Response of retinal RBC flow to hyperoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial vasoconstrictor response during LPS and 100% oxygen breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in MBL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovarian reserve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum level of FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: PSV (pulsatility index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Oxygenation Improvement (OI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Urine Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: time to maximum serum concentration (tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absorption rate constant (ka)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute bioavailability of sotalol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Female Sexual Function Questionnaire total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients with anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MRI-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: pacing capture threshold values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Electrocardiogram changes associated with KCNH2 mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time taken to extubate the trachea after cessation of propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean propofol infusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time when BIS was >60
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visceral fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: health-related stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: First-year mortality
Endpoint domain: Mortality/survival
Primary endpoint: Need for postoperative blood transfusions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: percent time with SpO2 <80%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in hospital emergency department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cost savings to the national economy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postpartum depression ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adenoma miss rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in urinary albumin/creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of early postoperative pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Mean AUCs for FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity scores for asthma symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physicians' and patients' global evaluations
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Recovery of corneal sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular surface staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subfoveal CT thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at supervised exercise sessions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: T (time to peak concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite primary end-point (death, myocardial infarction or urgent (re)intervention)
Endpoint domain: Mortality/survival
Primary endpoint: Angiographic success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Thrombus resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of ocular complications
Endpoint domain: Adverse events/effects
Primary endpoint: Dressing change interval time
Endpoint domain: Resource use
Primary endpoint: Growth rate of geographic atrophy (GA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RSA mean time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RSA percent decrement improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squat absolute power output improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: instance of glove perforation
Endpoint domain: Adverse events/effects
Primary endpoint: time to complete the repair
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: perceived difficulty of use
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in corrected QT interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: plasma level of CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: full alertness within 10 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSS scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: persistent TD
Endpoint domain: Adverse events/effects
Primary endpoint: treatment-emergent parkinsonism
Endpoint domain: Adverse events/effects